Home / Health / Cigna Cuts Weight Loss Drug Coverage for Employees
Cigna Cuts Weight Loss Drug Coverage for Employees
3 Jun
Summary
- Cigna is ending coverage for GLP-1 weight-loss drugs.
- The change affects employees in the Cigna Group Medical Plan.
- New coverage will cease starting July 1, 2026.
Effective July 1, 2026, Cigna is discontinuing coverage for GLP-1 weight-loss medications within its employee health plan. This decision impacts widely used drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
The insurer communicated these changes to employees on June 1 through materials concerning the Cigna Group Medical Plan. A Cigna spokesperson confirmed the policy shift.
The spokesperson indicated that the decision was made due to increased availability of these medications and the emergence of new treatment options. Cigna emphasized its continued dedication to employee well-being, offering a variety of weight management programs and resources.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
